On Feb. 25th, we are excited to have Dr. Eva Jingyi Liu, Senior Manager, Merck Innovation Hub China and Dr. Xianglong Zhao from Bio-X Institutes of Shanghai Jiao Tong University as our panel discussion speakers to discuss the application of organoids in tumor drug development and precision clinical medicine。
我们有幸邀请到默克中国创新中心高级经理刘静逸博士和上海交通大学Bio-X研究院的赵祥龙博士,在2月25日周四晚,共同探讨类器官芯片在肿瘤药物研发和临床精准医疗中的应用。